Is off-clamp robot-assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
02 2022
Historique:
pubmed: 5 6 2021
medline: 15 4 2022
entrez: 4 6 2021
Statut: ppublish

Résumé

To compare the functional outcomes of on- vs off-clamp robot-assisted partial nephrectomy (RAPN) within a randomized controlled trial (RCT). The CLOCK study (CLamp vs Off Clamp the Kidney during robotic partial nephrectomy; NCT02287987) is a multicentre RCT including patients with normal baseline function, two kidneys and masses with RENAL scores ≤ 10. Pre- and postoperative renal scintigraphy was prescribed. Renal defatting and hilum isolation were required in both study arms; in the on-clamp arm, ischaemia was imposed until the completion of medullary renorraphy, while in the off-clamp condition it was not allowed throughout the procedure. The primary endpoint was 6-month absolute variation in estimated glomerular filtration rate (AV-GFR); secondary endpoints were: 12, 18 and 24-month AV-GFR; 6-month estimated glomerular filtration rate variation >25% rate (RV-GFR >25); and absolute variation in ipsilateral split renal function (AV-SRF). The planned sample size was 102 + 102 cases, after taking account crossover of cases to the alternate study arm; a 1:1 randomization was performed. AV-GFR and AV-SRF were compared using analysis of covariation, and RV-GFR >25 was assessed using multivariable logistic regression. Intention-to-treat (ITT) and per-protocol analyses (PP) were performed. A total of 160 and 164 patients were randomly assigned to on- and off-clamp RAPN, respectively; crossover was observed in 14% and 43% of the on- and off-clamp arms, respectively. We were unable to find any statistically significant difference between on- vs off-clamp with regard to the primary endpoint (ITT: 6-month AV-GFR -6.2 vs -5.1 mL/min, mean difference 0.2 mL/min, 95% confidence interval [CI] -3.1 to 3.4 [P = 0.8]; PP: 6-month AV-GFR -6.8 vs -4.2 mL/min, mean difference 1.6 mL/min, 95% CI -2.3 to 5.5 [P = 0.7]) or with regard to the secondary endpoints. The median warm ischaemia time was 14 vs 15 min in the ITT analysis and 14 vs 0 min in the PP analysis. In patients with regular baseline function and two kidneys, we found no evidence of differences in functional outcomes for on- vs off-clamp RAPN.

Identifiants

pubmed: 34086393
doi: 10.1111/bju.15503
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-224

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 The Authors BJU International © 2021 BJU International.

Références

Ljungberg B, Albiges L, Abu-Ghanem Y et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019; 75: 799-810
Motzer RJ, Jonasch E, Agarwal N. NCCN guidelines index table of contents discussion. Kidney Cancer 2019; 64
Bravi CA, Larcher A, Capitanio U et al. Perioperative outcomes of open, laparoscopic, and robotic partial nephrectomy: a prospective multicenter observational study (the RECORd 2 project). Eur Urol Focus 2021; 7: 390-6
Kim SP, Murad MH, Thompson RH et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol 2012. [Epub ahead of print]. https://doi.org/10.1016/j.juro.2012.10.026
Capitanio U, Larcher A, Terrone C et al. End-stage renal disease after renal surgery in patients with normal preoperative kidney function: balancing surgical strategy and individual disorders at baseline. Eur Urol 2016; 70: 558-61
Antonelli A, Minervini A, Sandri M et al. Below safety limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and cancer-specific mortality in renal cell carcinoma. Eur Urol 2018; 74: 661-7
Antonelli A, Mari A, Longo N et al. Role of clinical and surgical factors for the prediction of immediate, early and late functional results, and its relationship with cardiovascular outcome after partial nephrectomy: results from the prospective multicenter RECORd 1 project. J Urol 2018; 199: 927-32
Mir MC, Autorino R, Porpiglia F. Ischemia time and beyond: the concept of global renal damage. Minerva Urol Nefrol 2018; 70: 447-9
Thompson RH, Lane BR, Lohse CM et al. Every minute counts when the renal hilum is clamped during partial nephrectomy. Eur Urol 2010; 58: 340-5
Greco F, Autorino R, Altieri V et al. Ischemia techniques in nephron-sparing surgery: a systematic review and meta-analysis of surgical, oncological, and functional outcomes. Eur Urol 2019; 75: 477-91
Cacciamani GE, Medina LG, Gill TS et al. Impact of renal hilar control on outcomes of robotic partial nephrectomy: systematic review and cumulative meta-analysis. Eur Urol Focus 2019; 5: 619-35
Antonelli A, Veccia A, Francavilla S et al. On-clamp versus off-clamp robotic partial nephrectomy: a systematic review and meta-analysis. Urologia 2019; 86: 52-62
Nahar B, Bhat A, Parekh DJ. Does every minute of renal ischemia still count in 2019? Unlocking the chains of a flawed thought process over five decades. Eur Urol Focus 2019; 5: 939-42
Cindolo L, Antonelli A, Sandri M et al. The role of vascular clamping during robot-assisted partial nephrectomy for localized renal cancer: rationale and design of the CLOCK randomized phase III study. Minerva Urol Nefrol 2019; 71: 96-100
Kutikov A, Uzzo RG. The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182: 844-53
Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-12
Borm GF, Fransen J, Lemmens WA. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol 2007; 60: 1234-8
Kaczmarek BF, Tanagho YS, Hillyer SP et al. Off-clamp robot-assisted partial nephrectomy preserves renal function: a multi-institutional propensity score analysis. Eur Urol 2013; 64: 988-93
Rosen DC, Paulucci DJ, Abaza R et al. Is off clamp always beneficial during robotic partial nephrectomy? A propensity score-matched comparison of clamp technique in patients with two kidneys. J Endourol 2017; 31: 1176-82
Mari A, Morselli S, Sessa F et al. Impact of the off-clamp endoscopic robot-assisted simple enucleation (ERASE) of clinical T1 renal tumors on the postoperative renal function: results from a matched-pair comparison. Eur J Surg Oncol 2018; 44: 853-8
Bertolo R, Simone G, Garisto J et al. Off-clamp vs on-clamp robotic partial nephrectomy: perioperative, functional and oncological outcomes from a propensity-score matching between two high-volume centers. Eur J Surg Oncol 2019; 45: 1232-7
Simone G, Capitanio U, Tuderti G et al. On-clamp versus off-clamp partial nephrectomy: propensity score-matched comparison of long-term functional outcomes. Int J Urol 2019; 26: 985-91
Antonelli A, Cindolo L, Sandri M et al. Predictors of the transition from off to on clamp approach during ongoing robotic partial nephrectomy: data from the CLOCK randomized clinical trial. J Urol 2019; 202: 62-8
Anderson BG, Potretzke AM, Du K et al. Comparing off-clamp and on-clamp robot-assisted partial nephrectomy: a prospective randomized trial. Urology 2019; 126: 102-9
Antonelli A, Cindolo L, Sandri M et al. Safety of on- vs off-clamp robotic partial nephrectomy: per-protocol analysis from the data of the CLOCK randomized trial. World J Urol 2020; 38: 1101-8
Porpiglia F, Fiori C, Bertolo R et al. Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. Eur Urol 2012; 62: 130-5
Mason R, Kapoor A, Liu Z et al. The natural history of renal function after surgical management of renal cell carcinoma: results from the Canadian Kidney Cancer Information System. Urol Oncol 2016; 34: 486.e1-7
Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res 2011; 2: 109-12
Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aust 2003; 179: 438-40
Lestingi JFP, Guglielmetti GB, Trinh Q-D et al. Extended versus limited pelvic lymph node dissection during radical prostatectomy for intermediate- and high-risk prostate cancer: early oncological outcomes from a randomized phase 3 trial. Eur Urol 2021; 79: 595-604

Auteurs

Alessandro Antonelli (A)

Urology Unit ASST Spedali Civili Hospital, University of Brescia, Brescia, Italy.
Urology Unit AUOI Verona, University of Verona, Verona, Italy.

Luca Cindolo (L)

Urology Unit D'Annunzio Hospital, University of Chieti, Chieti, Italy.

Marco Sandri (M)

Big & Open Data Innovation Laboratory (BODaI-Lab), University of Brescia, Brescia, Italy.

Alessandro Veccia (A)

Urology Unit ASST Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Filippo Annino (F)

Urology Unit San Donato Hospital, Arezzo, Italy.

Francesco Bertagna (F)

Nuclear Medicine Unit ASST Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Marco Carini (M)

Urology Unit Careggi Hospital, University of Florence, Florence, Italy.

Antonio Celia (A)

Urology Unit San Bassiano Hospital, Bassano Del Grappa, Italy.

Carlo D'Orta (C)

Urology Unit D'Annunzio Hospital, University of Chieti, Chieti, Italy.

Bernardino De Concilio (B)

Urology Unit San Bassiano Hospital, Bassano Del Grappa, Italy.

Maria Furlan (M)

Urology Unit ASST Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Valentina Giommoni (V)

Urology Unit San Donato Hospital, Arezzo, Italy.

Manuela Ingrosso (M)

Urology Unit D'Annunzio Hospital, University of Chieti, Chieti, Italy.

Andrea Mari (A)

Urology Unit Careggi Hospital, University of Florence, Florence, Italy.

Roberto Nucciotti (R)

Urology Unit Misericordia Hospital, Grosseto, Italy.

Catia Olianti (C)

Nuclear Medicine Unit Careggi Hospital, University of Florence, Florence, Italy.

Angelo Porreca (A)

Urology Unit Policlinico of Abano, Abano Terme, Italy.

Giulia Primiceri (G)

Urology Unit D'Annunzio Hospital, University of Chieti, Chieti, Italy.

Luigi Schips (L)

Urology Unit D'Annunzio Hospital, University of Chieti, Chieti, Italy.

Francesco Sessa (F)

Urology Unit Careggi Hospital, University of Florence, Florence, Italy.

Pierluigi Bove (P)

Urology Unit S. Carlo di Nancy Hospital, Roma, Italy.

Claudio Simeone (C)

Urology Unit ASST Spedali Civili Hospital, University of Brescia, Brescia, Italy.

Andrea Minervini (A)

Urology Unit Careggi Hospital, University of Florence, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH